TCL Archive GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer. November 2, 2007
TCL Archive NCI Advisors Approve $100M Set Aside for Physical Sciences-Oncology Centers. December 12, 2008
TCL Archive FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza December 26, 2014
TCL Archive In Brief: Pediatric Groups Endorse Merger Plan; NCI Charters Consumer Liaison Group November 13, 1998